It is fair to consider recommending regular MRI controls after defined intervals of 3-6 months at least for ALK-positive patients as already recommended for patients with advanced ALK-positive NSCLC by the German DGHO-Guideline for diagnosis and treatment of NSCLC. The gene discussed is ALK; the disease is non-small cell lung carcinoma.